Company news

Lipocine Inc. news in 2019

Lipocine Inc.'s news releases, calls and decks from 2019, newest first.

View company

Lipocine Announces Closing Of Public Offering Of Common Stock And Warrants

November 17, 2019

Lipocine Announces Pricing Of Public Offering Of Common Stock And Warrants

November 13, 2019

Lipocine Announces Launch Of Public Offering Of Common Stock And Warrants

November 12, 2019

Lipocine Announces Third Quarter 2019 Financial and Operational Results

November 11, 2019

Lipocine Receives Complete Response Letter for TLANDO(TM) from U.S. FDA

November 10, 2019

Lipocine To Present LPCN 1144 Poster Of Distinction At The Liver Meeting® 2019

September 30, 2019

First Biopsy Confirmed Nash Patient Dosed In Lipocine LiFT Study Of LPCN 1144

September 29, 2019

Lipocine Announces Presentations at the 20th Annual Fall Meeting of the Sexual Medicine Society of North America

September 22, 2019

Lipocine Announces Second Quarter 2019 Financial and Operational Results

August 6, 2019

Lipocine Receives FDA Clearance for Clinical Testing its NASH Candidate, LPCN 1144, in Expanded Target Population

July 22, 2019

Lipocine Seeks Injunction Against the Marketing of Clarus Therapeutics' JATENZO® for Testosterone Replacement Therapy

April 2, 2019

Decks in 2019